AR025341A1 - PHARMACEUTICAL COMPOSITIONS - Google Patents

PHARMACEUTICAL COMPOSITIONS

Info

Publication number
AR025341A1
AR025341A1 ARP000104311A ARP000104311A AR025341A1 AR 025341 A1 AR025341 A1 AR 025341A1 AR P000104311 A ARP000104311 A AR P000104311A AR P000104311 A ARP000104311 A AR P000104311A AR 025341 A1 AR025341 A1 AR 025341A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical compositions
active ingredient
pharmaceutical
salaceptab
phenylethoxy
Prior art date
Application number
ARP000104311A
Other languages
Spanish (es)
Original Assignee
Astrazeneca Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Uk Ltd filed Critical Astrazeneca Uk Ltd
Publication of AR025341A1 publication Critical patent/AR025341A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una composicion farmacéutica, un producto farmacéutico o un conjunto de elementos (kit) que incluye un primer ingrediente activo (A) que es 4-hidroxi-7-[2-[2-[3-[2--feniletoxi]propilsulfonil]etilamino]etil]-1,3-benzotiazol-2(3H)-ona o una salaceptab le para uso farmacéutico de la misma, y un segundo ingredienteactivo (B) que es un inhibidor de la PDE4, para usar en el tratamiento de enfermedades obstructivas de las vías respiratorias.A pharmaceutical composition, a pharmaceutical product or a set of elements (kit) that includes a first active ingredient (A) that is 4-hydroxy-7- [2- [2- [3- [2-phenylethoxy] propylsulfonyl] ethylamino ] ethyl] -1,3-benzothiazol-2 (3H) -one or a salaceptab for pharmaceutical use thereof, and a second active ingredient (B) that is a PDE4 inhibitor, for use in the treatment of obstructive diseases of the airways.

ARP000104311A 1999-08-18 2000-08-18 PHARMACEUTICAL COMPOSITIONS AR025341A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9902937A SE9902937D0 (en) 1999-08-18 1999-08-18 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
AR025341A1 true AR025341A1 (en) 2002-11-20

Family

ID=20416695

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000104311A AR025341A1 (en) 1999-08-18 2000-08-18 PHARMACEUTICAL COMPOSITIONS

Country Status (4)

Country Link
AR (1) AR025341A1 (en)
AU (1) AU6460200A (en)
SE (1) SE9902937D0 (en)
WO (1) WO2001011933A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR029984A1 (en) * 2000-07-27 2003-07-23 Smithkline Beecham Corp METHOD FOR REDUCING ASSOCIATED EXCERBATIONS COPD AMBITO
CA2543858C (en) 2003-11-21 2014-04-15 Theravance, Inc. Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
TW200738658A (en) 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds
TW200745067A (en) 2006-03-14 2007-12-16 Astrazeneca Ab Novel compounds
TW200833670A (en) 2006-12-20 2008-08-16 Astrazeneca Ab Novel compounds 569
GB0702458D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab Salts 668
US8569229B2 (en) 2008-02-07 2013-10-29 The Children's Hospital Of Philadelphia Compositions and methods which modulate G-protein signaling for the treatment of inflammatory disorders such as asthma and allergic conjunctivitis
EP2255189B8 (en) * 2008-02-07 2015-05-06 Michael M. Grunstein Compositions and methods which modulate g-protein signaling for the treatment of asthma
AU2009260899B2 (en) 2008-06-18 2012-02-23 Astrazeneca Ab Benzoxazinone derivatives acting as beta2-adrenoreceptor agonist for the treatment of respiratory disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9211172D0 (en) * 1992-05-27 1992-07-08 Fisons Plc Compounds

Also Published As

Publication number Publication date
AU6460200A (en) 2001-03-13
SE9902937D0 (en) 1999-08-18
WO2001011933A2 (en) 2001-02-22
WO2001011933A3 (en) 2001-06-14

Similar Documents

Publication Publication Date Title
DE60105448D1 (en) SOLID DISPERSIONS WITH NITRATIVE ACTIVE INGREDIENTS
EE04850B1 (en) Use of pyrimidine derivatives for the preparation of a medicament for the treatment of HIV infection, a compound, a pharmaceutical composition containing it, a process for the preparation of a compound and a composition, and a combination preparation for use in the treatment of HIV infection.
BR0207961A (en) Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases.
BR0108435A (en) Formulation and use of low dose entecavir
DE60336664D1 (en) NONNUCLEOSIDIC REVERSE TRANSCRIPTASE INHIBITORS
ECSP034774A (en) PIRAZOLOPIRIMMIDINAS AS THERAPEUTIC AGENTS
ECSP034773A (en) PIRAZOLOPIRIMMIDINAS AS THERAPEUTIC AGENTS
EE04927B1 (en) A pharmaceutical composition and its use in the manufacture of a medicament for the treatment of acute disorders
ES2190692B1 (en) PHARMACEUTICAL FORMULATION OF AMOXYCLINE AND POTASSIUM CLAVULANATE.
BRPI0313148B8 (en) solid matrix formulations of lamotrigine containing outer coating and perforation in such coating
EA200501690A1 (en) COMPOSITION INCLUDING PDE4 INHIBITOR AND PDE5 INHIBITOR
DE602005006278D1 (en) ORAL ANTIMICROBIAL PHARMACEUTICAL COMPOSITIONS
AR025341A1 (en) PHARMACEUTICAL COMPOSITIONS
BR0007294A (en) Improved pharmaceutical formulations
CL2003001415A1 (en) COMPOUNDS D DERIVED FROM NAFTIL, QUINOLINIL AND ISOQUINOLINIL UREA; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT AND PREVENTION OF PAIN CONDITIONS AND IN THE SYRNDROME OF THE IRRITABLE COLON AND ASSOCIATED CONDITIONS.
ATE454385T1 (en) HIV INTEGRASE INHIBITOR, PHARMACEUTICAL COMPOSITION AND THEREOF APPLICATION
BRPI0414558A (en) pharmaceutical composition comprising a p2x7 receptor antagonist and a non-steroidal anti-inflammatory drug
HUP0400553A2 (en) Pharmaceutical compositions
WO2003066597A3 (en) Guanidino compounds
ATE262893T1 (en) DOSAGE FORMS FOR THE TREATMENT OF ORAL MYCOSES
NO20073575L (en) Pharmaceutical compositions for the treatment of cellulite
AR025340A1 (en) PHARMACEUTICAL COMPOSITIONS
WO2001012167A3 (en) Pharmaceutical compositions comprising a 7-(2-aminoethyl)-benzothiazolone and an anticholinergic muscarinic antagonist
BR0012184B1 (en) indole-derived compounds, pharmaceutical formulation, and composition and use of the compounds in the manufacture of medicaments
NO323466B1 (en) New quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives, processes for their preparation, use thereof in medicaments for the treatment of pain, and pharmaceutical compositions comprising such derivatives